| Pentoxifylline for the treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized double-blind, placebo-controlled studies | |
| Tao.Zeng; Cui-Li.Zhang; Xiu-Lan.Zhao; Ke-Qin.Xie | |
| 刊名 | European Journal of Gastroenterology & Hepatology
 |
| 2014 | |
| 卷号 | 26期号:6页码:646-653 |
| 关键词 | nonalcoholic fatty liver disease meta-analysis pentoxifylline tumor necrosis factor alpha |
| DOI | 10.1097/MEG.0000000000000068 |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/5136373 |
| 专题 | 山东大学 |
| 作者单位 | Department of Environment and Health, Institute of Toxicology, Shandong University, 44 Wenhua West Road, Jinan 250012, Shandong Province, Ch |
| 推荐引用方式 GB/T 7714 | Tao.Zeng,Cui-Li.Zhang,Xiu-Lan.Zhao,et al. Pentoxifylline for the treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized double-blind, placebo-controlled studies[J]. European Journal of Gastroenterology & Hepatology,2014,26(6):646-653. |
| APA | Tao.Zeng,Cui-Li.Zhang,Xiu-Lan.Zhao,&Ke-Qin.Xie.(2014).Pentoxifylline for the treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized double-blind, placebo-controlled studies.European Journal of Gastroenterology & Hepatology,26(6),646-653. |
| MLA | Tao.Zeng,et al."Pentoxifylline for the treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized double-blind, placebo-controlled studies".European Journal of Gastroenterology & Hepatology 26.6(2014):646-653. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论